Table 4.
Group | Glucose (mmol/L) | Triglycerides (mmol/L) | Ca (mmol/L) | Mg (mmol/L) | Ca/Mg | SOD, Relative Activity | Testosterone, ng/mL |
---|---|---|---|---|---|---|---|
Control | 9.2 ± 1.4 | 2.9 ± 0.8 | 2.8 ± 0.3 | 0.9 ± 0.1 | 3.2 ± 0.2 | 100 ± 8% | 3.4 ± 1.9 |
BPH | 7.2 ± 1.4 ** | 2.4 ± 1.2 | 3.4 ± 0.6 * | 1.5 ± 0.8 * | 2.7 ± 0.7 | 67 ± 7% * | 13.5 ± 4.2 *** |
BPH + finasteride | 7.0 ± 0.3 ** | 2.2 ± 1.5 | 2.8 ± 0.3 # | 0.9 ± 0.1 # | 3.0 ± 0.2 | 98 ± 6% # | 18.2 ± 3.0 ***, # |
BPH + isoflavones | 6.8 ± 0.9 ** | 1.7 ± 1.4 | 2.9 ± 0.2 # | 1.0 ± 0.1 # | 2.9 ± 0.1 | 88 ± 5% | 14.2 ± 2.3 *** |
BPH + astaxanthin | 6.5 ± 1.2 ** | 1.8 ± 1.3 | 2.8 ± 0.3 # | 1.0 ± 0.1 # | 2.9 ± 0.2 | 111 ± 13% # | 17.9 ± 3.3 ***, # |
*, **, ***—p < 0.05, p < 0.01, p < 0.001 compared to control group (placebo); #—p < 0.05 compared to BPH group; assessed using ANOVA.